Kenvue Inc. (KVUE)
NYSE · Common stock · Perfumes, Cosmetics & Other Toilet Preparations
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow KVUE in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on KVUE and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
KVUE at a glance
Key statistics
$37.03B
Market capitalization
- Previous close
- $19.28
- Open
- $19.21
- Day range
- $19.07 – $19.26
- Volume
- 8.95M
- Average volume (30 sessions)
- 24.68M
- Shares outstanding
- 1.92B
- Price / earnings
- 22.3
- Earnings per share
- $0.86
- Price / book
- 3.5
- Price / sales
- 2.4
- Dividend yield
- 4.30%
- Beta (1 year, vs SPY)
- 0.10
Where the price sits in its year
52-week range
83% of the range
- Below the 52-week high
- -5.1%
- Above the 52-week low
- +36.3%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $17.91+7.6%
- 50-day average
- $18.33+5.2%
- 200-day average
- $18.09+6.6%
In the band above 70 that convention calls overbought. Strong trends can stay there for weeks.
+8.6%
1 week
+9.1%
1 month
+0.8%
3 months
+11.8%
Year to date
+26.1%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with KVUE
KVUE on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on KVUE.
See the plans →
Every planScreen names like KVUE
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on KVUE
Put KVUE on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on KVUE
See whether there is an open premium alert on KVUE, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
KVUE headlines
- What's Going On With Neutrogena Maker Kenvue Stock On Thursday?
Benzinga · Feb 12, 2026
- Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. · Dec 14, 2025
- Halper Sadeh LLC Encourages KVUE, SM, KMB, CDE Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc. · Nov 22, 2025
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)
GlobeNewswire Inc. · Nov 5, 2025
- Kimberly-Clark Stock Sell-Off Is an Overreaction After $49B Kenvue Deal
Investing.com · Nov 5, 2025
SEC Form 4, most recent first
Insider filings
Stevens Meredith
+35.8K
Chief Operations Officer · Grant or award
$614.97K · Oct 2, 2026
Stevens Meredith
−15.2K
Chief Operations Officer · Shares withheld for tax
$261.30K · Oct 2, 2026
Lawson Carlton
+36.6K
Group President EMEA & LA · Grant or award
$629.47K · Oct 2, 2026
Tillett Caroline
−8.5K
Chief Scientific Officer · Shares withheld for tax
$145.70K · Oct 2, 2026
Howlett Heather
−5.6K
CFO & CAO · Shares withheld for tax
$95.74K · Oct 2, 2026
Howlett Heather
+10.9K
CFO & CAO · Grant or award
$187.15K · Oct 2, 2026
Orlando Matthew
−14.7K
General Counsel · Shares withheld for tax
$253.68K · Oct 2, 2026
Orlando Matthew
+35.8K
General Counsel · Grant or award
$614.97K · Oct 2, 2026
About Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- Headquarters
- Summit, NJ
- Employees
- 22,000
- Listed since
- May 4, 2023
- Website
- kenvue.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.